Cyclerion Therapeutics, Inc.
🏢 View company profile →24Patents
24Active
24Granted
50Portfolio score
Filing activity: Sep 16, 2015 → May 22, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10517874B2 | sGC stimulators | Emerging Cross-Sectional Technologies | 3 | Active |
| US10639308B2 | sGC stimulators | Emerging Cross-Sectional Technologies | 3 | Active |
| US10889577B2 | Solid forms of an sGC stimulator | Chemistry; Metallurgy | 3 | Active |
| US10472363B2 | SGC stimulators | Emerging Cross-Sectional Technologies | 2 | Active |
| US11708361B2 | Processes and intermediates for the preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 2 | Active |
| US11274096B2 | Processes and intermediates for the preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 2 | Active |
| US10844064B2 | sGC stimulators | Chemistry; Metallurgy | 2 | Active |
| US10858363B2 | SGC stimulators | Emerging Cross-Sectional Technologies | 2 | Active |
| US11834444B2 | Processes for preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 2 | Active |
| US11466015B2 | Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators | Chemistry; Metallurgy | 2 | Active |
| US11466014B2 | Process for preparing soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 1 | Active |
| US11319308B2 | Processes for preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 1 | Active |
| US12030874B2 | Processes and intermediates for the preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 1 | Active |
| US11731977B2 | SGC stimulators | Emerging Cross-Sectional Technologies | 0 | Active |
| US11180493B2 | SGC stimulators | Chemistry; Metallurgy | 0 | Active |
| US11207323B2 | sGC stimulators | Emerging Cross-Sectional Technologies | 0 | Active |
| US12275724B2 | Processes and intermediates for the preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 0 | Active |
| US11690828B2 | Treatment of CNS diseases with sGC stimulators | Human Necessities | 0 | Active |
| US12247025B2 | Processes for preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 0 | Active |
| US11572358B2 | Solid forms of an sGC stimulator | Chemistry; Metallurgy | 0 | Active |
| US11357777B2 | Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH) | Human Necessities | 0 | Active |
| US11389449B2 | Treatment of metabolic syndrome with an sGC stimulator | Human Necessities | 0 | Active |
| US11773089B2 | Process for preparation of soluble guanylate cyclase stimulators | Chemistry; Metallurgy | 0 | Active |
| US10927136B2 | Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.